Freestyle Insulinx
Payments companies reported to CMS as associated with Freestyle Insulinx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Freestyle Insulinx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Freestyle Insulinx
These are the largest totals companies reported as associated with Freestyle Insulinx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Shideh Majidi | Washington, DC | Pediatric Endocrinology | $374.85 |
| Hoaitram Dinh | Stockton, CA | Adult Health (Nurse Practitioner) | $279.72 |
| Doris Estrada | Washington, DC | Pediatric Endocrinology | $274.95 |
| Fran Cogen | Washington, DC | Pediatric Endocrinology | $274.95 |
| Chirag Kapadia | Phoenix, AZ | Pediatric Endocrinology | $249.75 |
| Paul Lewis | Clearwater, FL | Family Medicine | $199.80 |
| Linda Row | Walnut Creek, CA | Internal Medicine | $199.80 |
| Mamatha Palanati | Bellevue, WA | Family Medicine | $199.60 |
| Daniel So | Arlington Heights, IL | Endocrinology, Diabetes & Metabolism | $159.93 |
| Kara Larter | Phoenix, AZ | Women'S Health (Nurse Practitioner) | $149.85 |
Prescribed Freestyle Insulinx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.